Efficacy of a standard Argon Plasma Coagulation (APC) catheter, used after submucosal injection in patients with Barrett’s esophagus and low-grade dysplasia (LGD)
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S464
DOI: 10.1055/s-0044-1783873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von S. Michopoulos und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aims Evaluate the efficacy of standard APC catheter after submucosal injection for ablation of BE with LGD Methods Naïve or after previous treatments patients with BE and LGD prospectively evaluated. NaCl 0.9% was injected submucosally with a 23 G needle followed by APC application (ERBE ICC 200 with APC 300, 45Watts or ESG-300 generator with APU-300, Pulse fast 40W). Patients were sedated with propofol. High-definition endoscopes (OLYMPUS GIF ITH 190) with a transparent cap, acetic acid 2% and NBI were used. After submucosal injection, a first ablation with APC of a large BE surface was performed and then debris were removed by the cap, followed by a second ablation. The same procedure was repeated, with special attention not to ablate large circumferential areas. Patients were under high dose PPIs and evaluated every 2-3 months till complete BE eradication. Biopsies were taken according to Seattle protocol during follow-up Results 34 patients, 32 males (94.1%), 56.4±11.9 years old were evaluated. Initial diagnosis was: 21 patients with LGD (61.8%), 8 with HGD (23.5%), and 5 with intramucosal cancer (14.7%). Ten patients (29.41%) had previous endoscopic mucosal resection (EMR), 9 (22.6%) radiofrequency ablation (RFA), and 15 (44.1%) APC as first line treatment. Mean BE length with LGD, at the beginning of APC treatment was 4.12±2.68 cm and at the end of the treatment median was 0 cm (25 th -75 th : 0-1, min-max: 0-5). In total 23 (67.65%) patients completely eradicated BE. No smoking (HR: 2.76, 95% C.I. 1.12 – 6.84, p=0.03) and no previous treatment before APC (HR:2.94, 95% C.I. 1.16 – 7.46, p=0.02) were favorable factors for BE eradication. Total need for APC interventions and initial BE length positively correlated (Pearson’s r=0.69, p
Zitieren
APA
Michopoulos, S., Ioannou, A., Axiaris, G., Baxevanis, P., Pardalis, P., Koumentakis, C., Pantelakis, E., Leonidakis, G., Zampeli, E., & Petraki, K. (2024). Efficacy of a standard Argon Plasma Coagulation (APC) catheter, used after submucosal injection in patients with Barrett’s esophagus and low-grade dysplasia (LGD). Endoscopy, 56(S 02 S 02), S464. https://doi.org/10.1055/s-0044-1783873
Vancouver
Michopoulos S, Ioannou A, Axiaris G, Baxevanis P, Pardalis P, Koumentakis C, et al. Efficacy of a standard Argon Plasma Coagulation (APC) catheter, used after submucosal injection in patients with Barrett’s esophagus and low-grade dysplasia (LGD). Endoscopy. 2024;56(S 02 S 02):S464. doi:10.1055/s-0044-1783873
BibTeX
@article{Michopoulos2024,
author = {Michopoulos, S. and Ioannou, A. and Axiaris, G. and Baxevanis, P. and Pardalis, P. and Koumentakis, C. and Pantelakis, E. and Leonidakis, G. and Zampeli, E. and Petraki, K.},
title = {Efficacy of a standard Argon Plasma Coagulation (APC) catheter, used after submucosal injection in patients with Barrett’s esophagus and low-grade dysplasia (LGD)},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S464},
doi = {10.1055/s-0044-1783873}
}
EUVIMED